Furthermore, recent studies have identified ecDNA amplification of MYC paralogs in a minority of de novo SCLC tumor samples (60) and posttreatment SCLC models (61), although the prevalence of underlying chromothripsis in such cases remains to be determined. The gene discussed is MYC; the disease is neoplasm.